Can you get medical cannabis for IBS in the UK?

Irritable bowel syndrome appears on UK clinic condition lists, and it has one of the thinnest evidence bases of anything on those lists. The controlled studies that exist measured gut movement in a laboratory, not whether anyone felt better.

Is irritable bowel syndrome treated with medical cannabis in the UK?

IBS appears on the condition lists UK private clinics publish, and is assessed case by case. It is not an NHS treatment, nothing is licensed for it, and the evidence behind it is weaker than for almost anything else on this site.

UK management of IBS, set out in NICE guideline CG61, starts with diet and lifestyle: regular meals, adjusting fibre by IBS subtype, limiting caffeine and alcohol, and a low-FODMAP diet delivered by a trained dietitian where first-line advice has not worked. Antispasmodics, laxatives or loperamide are used by symptom pattern, low-dose tricyclic antidepressants are recommended where those fail, and psychological therapies including gut-directed hypnotherapy have real evidence behind them.

A specialist will want to know that route has genuinely been travelled — and that the diagnosis is right. IBS is a diagnosis made after coeliac disease, IBD and other causes have been considered, not a label for unexplained gut symptoms.

What the evidence actually shows

There is no randomised trial showing that cannabis-based medicines relieve IBS symptoms. The controlled studies that exist measured how quickly things move through the colon — a physiological measure, not a patient outcome.

A randomised pharmacodynamic and pharmacogenetic trial published in Neurogastroenterology and Motility gave dronabinol, a synthetic THC, or placebo to patients with IBS and measured colonic transit and motility. It found reduced fasting colonic motility, with effects greatest in diarrhoea-predominant IBS and influenced by genetic variation in cannabinoid receptor and endocannabinoid enzyme genes. That is a real pharmacological effect on the gut. It is not a demonstration that people's symptoms improved.

Systematic reviews of the area consistently conclude that evidence for cannabinoids in IBS is insufficient to support their use. Where UK patients with IBS are prescribed privately, the rationale is generally borrowed from the chronic pain literature rather than from IBS-specific evidence, and a specialist should say so. That distinction is worth holding on to. Reasoning across from another condition is not the same as evidence in yours, and it means the honest position is uncertainty rather than confidence. A specialist who is candid about that is giving you better information than one who is not.

What a specialist will want to see

There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For irritable bowel syndrome they will typically look at:

• Whether IBS has been properly diagnosed and other causes excluded, including coeliac disease and IBD
• Any red flag symptoms — unexplained weight loss, rectal bleeding, anaemia, a change in bowel habit over 60
• Your IBS subtype: diarrhoea-predominant, constipation-predominant or mixed
• Whether you have had dietary treatment with a dietitian, including a properly supervised low-FODMAP trial
• Whether antispasmodics, low-dose tricyclics or gut-directed psychological therapy have been tried
• Your current or past cannabis use, and any history of cyclical vomiting

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks and reasons a specialist may say no

There is a specific trap in IBS. Cannabinoid hyperemesis syndrome — cycles of severe nausea and vomiting, often relieved temporarily by hot showers — is caused by regular heavy cannabis use and is frequently mistaken for a functional gut disorder. Treating it with more cannabis makes it worse.

Cannabis also slows gut transit, which may help diarrhoea-predominant IBS and worsen constipation-predominant IBS. Symptom relief in a condition diagnosed by exclusion carries the risk of masking something that was missed, so red flag symptoms should always be investigated rather than medicated. The general cautions on drowsiness, driving, psychosis history and pregnancy apply as elsewhere.

How medical cannabis is thought to help

Any proposed mechanism in IBS is general and unproven, and this is a page where that caveat carries real weight. The broad idea is that the body has an endocannabinoid system — receptors and signalling molecules found throughout the nervous system and the gut — that is involved in pain, gut motility and the way the brain and gut communicate, and the cannabinoids in cannabis act on that system.

THC and CBD affect it in different ways, which is why products are described by the balance between them rather than as one medicine. Because gut function and pain perception are both linked to endocannabinoid signalling, there is a theoretical route by which symptoms might change — and the controlled studies confirm cannabinoids can measurably alter how quickly the gut moves. What no study has shown is that this translates into people with IBS feeling better. A mechanism you can describe is not the same as a benefit you can rely on. For the biology, see the endocannabinoid system explained and THC and CBD explained.

What treatment involves in practice

If a specialist does decide a supervised trial is justified, the approach is the same cautious one used across this field: start at a low dose, increase slowly, and review honestly against a clear symptom target agreed in advance.

The usual formats are oils or capsules by mouth and dried flower for vaporising. Oils are steady and simple to measure; vaporised flower acts faster but wears off sooner. Your specialist chooses the format and cannabinoid balance with you, and there is no dose that suits everyone — how a dose is set and adjusted is covered in how a dose is decided and adjusted, and the formats in how cannabis-based medicines are taken.

Follow-up matters especially here, because IBS is a diagnosis of exclusion. Reviews check whether symptoms have genuinely improved and whether side effects are tolerable, and a good specialist stays alert to anything that suggests a cause other than IBS. Treatment that is not clearly helping is stopped rather than continued out of momentum. How soon any effect appears varies — see how long cannabis medicines take to work — and the common unwanted effects are in side effects of cannabis-based medicines.

Living with treatment day to day

A prescription brings practical responsibilities that are easier to handle if you plan for them, particularly around driving, work and travel.

• Driving. THC-containing products can impair driving, and you must never drive while impaired; a medical defence applies when a prescribed medicine is taken as directed. See driving with a medical cannabis prescription.
• Work and testing. A workplace test can detect THC, so it is worth knowing your position early: medical cannabis, drug testing and work.
• Travel. Taking a prescribed cannabis-based medicine abroad depends on the destination country's law: travelling abroad with a prescription.
• Your GP. Telling your GP keeps your record complete and your care joined up: telling your GP.

If you want to take this further

The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If irritable bowel syndrome is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Patient guide · Written by the Flora House editorial team · Last reviewed: 7 October 2026